Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments

Detalles Bibliográficos
Autor principal: Tamargo, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2019
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955741/
https://www.ncbi.nlm.nih.gov/pubmed/31933693
http://dx.doi.org/10.15420/ecr.2019.14.3.CG1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955741/
https://www.ncbi.nlm.nih.gov/pubmed/31933693
http://dx.doi.org/10.15420/ecr.2019.14.3.CG1

Ejemplares similares